The most comprehensive diabetes knowledge base online. Understand your diabetes. Know your supplies. Make better decisions.
MDS Diabetes
Diabetes
Encyclopedia
Shop Supplies β†’
Researchβœ“ Reviewed for accuracy

Stopping Tirzepatide Reverses Heart Health Gains

When people stopped taking tirzepatide, most regained weight within a year. The more weight regained, the worse their blood sugar, blood pressure, and cholesterol became.

M
MDS Diabetes Team
Β·4 min read
𝕏f
Key takeaways
  • βœ“People who kept off most weight (under 25% regain) maintained nearly all their improved waist size, cholesterol, and insulin levels
  • βœ“The study clearly maps how much heart and metabolic health worsens based on how much weight is regained β€” giving patients a useful benchmark
  • βœ“Findings reinforce that continued obesity treatment preserves real, measurable health benefits beyond just the number on the scale
Quick specs
JournalJAMA internal medicine
Year2026
PMID41284285

What This Study Found

This research looked at what happens to people's health when they stop taking tirzepatide (Zepbound/Mounjaro), a medication used for obesity and diabetes. The study followed 308 adults who had already lost significant weight on tirzepatide for 36 weeks, then stopped the medication.

The Key Problem: Weight Comes Back

After stopping tirzepatide, most people regained weight within one year. Researchers divided participants into four groups based on how much of their lost weight they regained:

  • Less than 25% regained – kept most of their weight loss (best outcome)
  • 25% to 50% regained – moderate weight regain
  • 50% to 75% regained – significant weight regain
  • 75% or more regained – regained nearly all lost weight (worst outcome)

What Happened to Heart and Metabolic Health

The more weight people regained, the more their cardiometabolic health worsened. Here is what changed after stopping tirzepatide:

Waist Circumference

  • Less than 25% regain: increased by only 0.8 cm (barely any change)
  • 75%+ regain: increased by 14.7 cm β€” a significant rise

Blood Pressure (Systolic)

  • Even those who kept most weight off saw blood pressure rise by about 7 points
  • Those who regained the most saw a 10-point rise

Blood Sugar (HbA1c)

  • People who kept weight off: small rise of 0.14%
  • People who regained most weight: larger rise of 0.35%

Cholesterol and Insulin

  • Those who regained 75%+ of weight saw cholesterol worsen by nearly 11% and fasting insulin rise by 26%
  • Those who kept weight off showed little to no meaningful change in these measures

The Silver Lining

People who managed to keep their weight loss (less than 25% regain) largely maintained their improved waist size, cholesterol, and insulin levels. This shows that the health benefits of tirzepatide can be preserved β€” but only if weight loss is maintained.

What This Means for You

This study sends a clear message: obesity is a long-term condition that often requires ongoing treatment. Stopping medication without a plan to maintain weight loss can undo hard-won health improvements relatively quickly. Talk to your doctor before making any changes to your medication.

References & Sources

Frequently asked questions

Your HbA1c (a measure of average blood sugar) is likely to rise after stopping tirzepatide, especially if you regain weight. People who regained 75% or more of their lost weight saw HbA1c increase by 0.35%, while those who kept most weight off saw only a 0.14% rise.
Editorial note
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diabetes management. Last reviewed: July 16, 2026 by the MDS Diabetes editorial team.
What to do next
πŸ“š
Read more Research articles
Explore all guides in this topic
β†’
πŸ›’
Shop related supplies at MDS
FSA/HSA eligible Β· Free shipping $60+
β†’
Topics
tirzepatideweight regainobesitycardiometabolic healthblood sugarblood pressurecholesterolresearch

Related articles

Ask Mila about diabetes